Streetbeat News

Analyst Ratings

ABBV

AMGN

OGN

Wall Street's most accurate analysts recommend holding three health care stocks with over 3% dividend yields: Organon & Co. (OGN), AbbVie Inc. (ABBV), and Amgen Inc. (AMGN). These companies have high free cash flows and reward shareholders with high dividend payouts.

Portfolio Pulse from Lisa Levin

June 08, 2023 | 1:09 pm

RVPH

In the last quarter, Reviva Pharmaceuticals (NASDAQ: RVPH) received 3 bullish and 1 somewhat bullish analyst ratings. The company has an average 12-month price target of $16.25, with a high of $20.00 and a low of $10.00. The average price target has increased by 62.5% over the past month.

Portfolio Pulse from Benzinga Insights

June 08, 2023 | 1:02 pm

QS

In the last 3 months, 4 analysts have offered 12-month price targets for QuantumScape (NYSE:QS), with an average price target of $4.5, representing a 32.53% decrease from the previous average price target of $6.67.

Portfolio Pulse from Benzinga Insights

June 08, 2023 | 1:02 pm

EAT

Over the past 3 months, 8 analysts have published their opinion on Brinker International (NYSE:EAT) stock, with an average price target of $40.19, implying an upside from the current price of $36.39. The average price target has increased by 2.6% over the past month.

Portfolio Pulse from Benzinga Insights

June 08, 2023 | 1:01 pm

SCPH

Over the past 3 months, 4 analysts have published bullish opinions on scPharmaceuticals (NASDAQ:SCPH) stock, with an average 12-month price target of $18.5. The average price target has increased by 42.31% over the past month.

Portfolio Pulse from Benzinga Insights

June 08, 2023 | 1:01 pm

FIVN

Over the past 3 months, 6 analysts have published their opinion on Five9 (NASDAQ:FIVN) stock, with 4 bullish, 1 somewhat bullish, and 1 indifferent. The average 12-month price target is $85.17, representing a 9.39% decrease from the previous average of $94.00.

Portfolio Pulse from Benzinga Insights

June 08, 2023 | 1:00 pm

RVPH

Benchmark analyst Bruce Jackson initiates coverage on Reviva Pharmaceuticals (NASDAQ:RVPH) with a Speculative Buy rating and announces a price target of $17.

Portfolio Pulse from richadhand@benzinga.com

June 08, 2023 | 12:46 pm

CVAC

SVB Securities analyst Mani Foroohar initiates coverage on CureVac (NASDAQ:CVAC) with an Outperform rating and a price target of $13.

Portfolio Pulse from richadhand@benzinga.com

June 08, 2023 | 12:45 pm

ROIV

B of A Securities analyst Chi Fong initiates coverage on Roivant Sciences (NASDAQ:ROIV) with a Neutral rating and a price target of $10.5.

Portfolio Pulse from richadhand@benzinga.com

June 08, 2023 | 12:44 pm

PACW

Odeon Capital analyst Dick Bove has initiated coverage on PacWest Banc (NASDAQ:PACW) with a Hold rating and a price target of $8.75.

Portfolio Pulse from richadhand@benzinga.com

June 08, 2023 | 12:43 pm